Financing was co-led by Forbion and General Atlantic, with participants including RA Capital Management, OrbiMed, and Lilly Asia Ventures.
LondonWorld on MSN41m
Elcella: London scientists develop 'all-natural' alternative to weight loss jabs like OzempicThe Elcella pill unlocks the body’s naturally occurring hormones in the colon, to send ‘fullness’ messages to the brain, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback